Phaos Technology Holdings (Cayman) (POAS) Total Debt (2024 - 2025)

Phaos Technology Holdings (Cayman) (POAS) posted Total Debt of $106508.0 for Q4 2025, up 6.26% on a QoQ basis from $100230.1 in Q2 2025.

Phaos Technology Holdings (Cayman) (POAS) Total Debt (2024 - 2025) Analysis & Trends

Phaos Technology Holdings (Cayman)'s Total Debt history runs 2 years deep, the most recent figure standing at $106508.0 for Q4 2025.

Quarterly Total Debt changed N/A year-over-year to $106508.0 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $106508.0 (changed N/A YoY) and the FY2025 annual result came in at $100321.9, down 76.48% from the prior year.
Total Debt was $106508.0 for Q4 2025 at Phaos Technology Holdings (Cayman), up from $100230.1 in the prior quarter.
Across five years, Total Debt topped out at $426507.1 in Q2 2024 and bottomed at $100230.1 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Abbott Laboratories	183.13 Bn	175.84 Bn	6.27 Bn	34.05 Bn
2	Stryker	128.86 Bn	125.99 Bn	3.81 Bn	14.72 Bn
3	Medtronic	108.95 Bn	99.73 Bn	6.41 Bn	27.96 Bn
4	Boston Scientific	68.42 Bn	66.97 Bn	3.61 Bn	11.03 Bn
5	Edwards Lifesciences	48.30 Bn	44.63 Bn	1.29 Bn	598.50 Mn
6	GE HealthCare Technologies	28.33 Bn	26.04 Bn	1.98 Bn	10.14 Bn
7	Dexcom	28.32 Bn	27.20 Bn	750.30 Mn	-
8	Smith & Nephew	26.89 Bn	26.31 Bn	-	3.18 Bn
9	Koninklijke Philips	25.43 Bn	22.30 Bn	2.07 Bn	9.48 Bn
10	Phaos Technology Holdings (Cayman)	6.17 Mn	6.12 Mn	-	106,508.00

Download Data